Log In
Sign Up
Forgotten Password
Upgrade to a paid membership and never see an advert again!
Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock MEDELLA THERAPEUTICS LIMITED's Credit Report?
Buy This Report
Upgrade to Lite
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to Lite
217,
Portobello,
Sheffield,
Sheffield,
S1 4DP
MEDELLA THERAPEUTICS LIMITED
Private limited with Share Capital
Company is dissolved
08 February 2007
72190 Other research and experimental development on natural sciences and engineering - Other research and experimental development on natural sciences and engineering
Available to 29 Sep 2017. Next accounts due by 30 Sep 2018
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| IP2IPO SERVICES LIMITED | Director | ||
| Dr Timothy Skerry | Director | ||
| Mr Gareth Owain Richards | Director |
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £5,502.00 | £10,710.00 | £39,455.00 | £4,876.00 | £4,644.00 |
| Net Worth | -£967,630.00 | -£942,332.00 | -£863,644.00 | -£762,028.00 | -£637,318.00 |
| Total Current Liabilities | £6,149.00 | £18,425.00 | £20,526.00 | £770,158.00 | £644,179.00 |
| Total Current Assets | £13,434.00 | £18,427.00 | £39,759.00 | £8,130.00 | £6,861.00 |
Detailed answers about MEDELLA THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
MEDELLA THERAPEUTICS LIMITED was officially incorporated on 08 February 2007 and is registered under company number 06090354. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
MEDELLA THERAPEUTICS LIMITED's current status is NonActive. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
MEDELLA THERAPEUTICS LIMITED operates in the following sector: 72190 Other research and experimental development on natural sciences and engineering - Other research and experimental development on natural sciences and engineering . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
The registered office address of MEDELLA THERAPEUTICS LIMITED is 217, Portobello, Sheffield, Sheffield, S1 4DP. This is the official address filed with Companies House for legal and statutory correspondence.
Based on the latest accounts up to 29 Sep 2017, MEDELLA THERAPEUTICS LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Sep 2018. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.